Reply to N. Biran et al

Affiliations

¹ Sagar Lonial, MD, Madhav V. Dhodapkar, MBBS, MD, Department of Hematology and Medical Oncology and the Winship Cancer Institute, Emory University, Atlanta, GA; and S. Vincent Rajkumar, MD, Division of Hematology, Mayo Clinic, Rochester, MN.

Comment

Sagar Lonial et al. J Clin Oncol. 2020.

. 2020 Apr 20;38(12):1368-1369.

doi: 10.1200/JCO.20.00042. Epub 2020 Mar 11.

¹ Sagar Lonial, MD, Madhav V. Dhodapkar, MBBS, MD, Department of Hematology and Medical Oncology and the Winship Cancer Institute, Emory University, Atlanta, GA; and S. Vincent Rajkumar, MD, Division of Hematology, Mayo Clinic, Rochester, MN.

No abstract available

Comment on

Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma.
Lonial S, Jacobus S, Fonseca R, Weiss M, Kumar S, Orlowski RZ, Kaufman JL, Yacoub AM, Buadi FK, O'Brien T, Matous JV, Anderson DM, Emmons RV, Mahindra A, Wagner LI, Dhodapkar MV, Rajkumar SV. Lonial S, et al. J Clin Oncol. 2020 Apr 10;38(11):1126-1137. doi: 10.1200/JCO.19.01740. Epub 2019 Oct 25. J Clin Oncol. 2020. PMID: 31652094 Free PMC article. Clinical Trial.
Treatment of Smoldering Myeloma: Problems With Study Design as well as Biological and Clinical Implications.
Biran N, Vesole DH, Donato ML, Ip A, Kaur G, Goldberg S, Siegel DS. Biran N, et al. J Clin Oncol. 2020 Apr 20;38(12):1367-1368. doi: 10.1200/JCO.19.02972. Epub 2020 Mar 11. J Clin Oncol. 2020. PMID: 32160077 No abstract available.